Evidence map›Paper›PMID 39353469›Full record

ArticleBiochimica et biophysica acta. Molecular cell research2025

AGR2 knockdown induces ER stress and mitochondria fission to facilitate pancreatic cancer cell death.

Philip Salu, Daniel Tuvin, Katie M Reindl

Abstract read
In one paragraph

Article in Biochimica et biophysica acta. Molecular cell research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Philip SaluNorth Dakota State University, Department of Biological Sciences, Fargo, ND, United States of America.
Daniel TuvinRoger Maris Cancer Center, Sanford Health, Fargo, ND, United States of America.
Katie M ReindlNorth Dakota State University, Department of Biological Sciences, Fargo, ND, United States of America. Electronic address: katie.reindl@ndsu.edu.

Funding

Targeting CLEC-2/podoplanin as a therapeutic strategy for pancreatic cancerP20GM109024 · NIGMS · NORTH DAKOTA STATE UNIVERSITY · PI Sanku Mallik · 2016 to 2026
$20.5M
120kV Transmission Electron Microscope for Core Electron Microscopy FacilityS10OD030309 · OD · NORTH DAKOTA STATE UNIVERSITY · PI PAYNE, SCOTT ANDREW · 2021 to 2021
$574k
GSTP1 as a therapeutic target for pancreatic cancerR15CA249714 · NCI · NORTH DAKOTA STATE UNIVERSITY · PI REINDL, KATIE · 2020 to 2020
$434k
NCI NIH HHS R15 CA249714NIGMS NIH HHS P20 GM109024NIH HHS S10 OD030309
6 · The paper itself

Abstract

Anterior gradient 2 (AGR2) is often overexpressed in many human cancers, including pancreatic ductal adenocarcinoma (PDAC). Elevated AGR2 expression is known to play a critical role in tumor development, progression, and metastasis and positively correlates with poor patient survival. However, the relationship between AGR2 expression and tumor growth is not fully understood. Our study aims to investigate the impact of AGR2 knockdown on the survival of two pancreatic cancer cell lines, HPAF-II and PANC-1, that exhibit high AGR2 expression. This study revealed that the knockdown of AGR2 expression through an inducible shRNA-mediated approach reduced the proliferative ability and colony-forming potential of PDAC cells compared to scramble controls. Significantly, knocking down AGR2 led to the inhibition of multiple protein biosynthesis pathways and induced ER stress through unfolded protein response (UPR) activation. AGR2 knockdown induced ER stress and increased mitochondrial fission, while mitochondrial fusion remained unaffected. Ultimately, apoptotic cell death was heightened in AGR2 knockdown PDAC cells compared to the controls. Overall, these data reveal a new axis involving AGR2-ER stress-associated mitochondrial fission that could be targeted to improve PDAC patient outcomes.

Indexed as

Carcinoma, Pancreatic DuctalEndoplasmic Reticulum StressMitochondrial DynamicsMucoproteinsOncogene ProteinsPancreatic NeoplasmsApoptosisCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansMitochondriaProteinsUnfolded Protein ResponseAGR2 protein, humanMucoproteinsOncogene ProteinsProteinsAnterior gradient 2 (AGR2)ER stressMitochondria dysfunctionPancreatic ductal adenocarcinoma (PDAC)Unfolded protein response (UPR)

Identifiers

PMID39353469
PMCPMC11608140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.